Pioneering technology focused on the market

The Innostroke prototype is the first functional version of our technology, previously used in international clinical studies to validate its accuracy and clinical utility.

Mobile App

Development of a mobile app that interprets data from EGC devices and incorporates patient-specific information, facilitating early estimation of stroke risk.

Integration with portable devices

Through its integration with ECG devices, the prototype enables real-time data collection, facilitating the obtaining of predictive results in both clinical and non-clinical settings.

Evaluation of genetic and molecular data

By integrating genetic and molecular data and combining it with cardiovascular and lifestyle information, a detailed risk profile is provided that helps healthcare professionals better understand the status of each patient.

Interoperability and data security

The prototype ensures data privacy, respecting the highest cybersecurity standards and complying with European regulations on AI and health.